JPS6041077B2
(ja)
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体
|
US4323581A
(en)
|
1978-07-31 |
1982-04-06 |
Johnson & Johnson |
Method of treating carcinogenesis
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
US4923986A
(en)
|
1987-03-09 |
1990-05-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Derivatives of physiologically active substance K-252
|
US4904768A
(en)
|
1987-08-04 |
1990-02-27 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside 4'-phosphate derivatives
|
WO1989007105A1
(fr)
|
1988-02-04 |
1989-08-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de staurosporine
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
US6410010B1
(en)
|
1992-10-13 |
2002-06-25 |
Board Of Regents, The University Of Texas System |
Recombinant P53 adenovirus compositions
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
AU2866992A
(en)
|
1991-10-10 |
1993-05-03 |
Schering Corporation |
4'-(n-substituted-n-oxide)staurosporine derivatives
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
CA2123096A1
(fr)
|
1991-11-08 |
1993-05-13 |
Beat J. Knusel |
Compositions contenant des composes k-252 pour la potentialisation de l'activite neurotrophine
|
GB9300059D0
(en)
|
1992-01-20 |
1993-03-03 |
Zeneca Ltd |
Quinazoline derivatives
|
US5948898A
(en)
|
1992-03-16 |
1999-09-07 |
Isis Pharmaceuticals, Inc. |
Methoxyethoxy oligonucleotides for modulation of protein kinase C expression
|
US5756494A
(en)
|
1992-07-24 |
1998-05-26 |
Cephalon, Inc. |
Protein kinase inhibitors for treatment of neurological disorders
|
US5621100A
(en)
|
1992-07-24 |
1997-04-15 |
Cephalon, Inc. |
K-252a derivatives for treatment of neurological disorders
|
CA2143335C
(fr)
|
1992-08-31 |
2000-03-14 |
Thierry Boon-Falleur |
Nonapeptide isole derive du gene mage-3 et presente par hla-a1, et son utilisation
|
DE69331228T4
(de)
|
1992-09-21 |
2002-09-05 |
Kyowa Hakko Kogyo Kk |
Heilmittel für thrombozytopenia
|
DK1167384T3
(da)
|
1992-10-28 |
2007-04-10 |
Genentech Inc |
Vaskular endotheliel cellevækstfaktor antagonister
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
CA2167042A1
(fr)
|
1993-07-15 |
1995-01-26 |
Kyle J. Lindstrom |
Imidazo[4,5-c]pyridin-4-amines
|
US5478932A
(en)
|
1993-12-02 |
1995-12-26 |
The Board Of Trustees Of The University Of Illinois |
Ecteinascidins
|
PT817627E
(pt)
|
1993-12-23 |
2005-07-29 |
Lilly Co Eli |
Inibidores da proteina cinase c
|
US5587459A
(en)
|
1994-08-19 |
1996-12-24 |
Regents Of The University Of Minnesota |
Immunoconjugates comprising tyrosine kinase inhibitors
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
PT817775E
(pt)
|
1995-03-30 |
2002-01-30 |
Pfizer |
Derivados de quinazolina
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
US6331555B1
(en)
|
1995-06-01 |
2001-12-18 |
University Of California |
Treatment of platelet derived growth factor related disorders such as cancers
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
WO1997007081A2
(fr)
|
1995-08-11 |
1997-02-27 |
Yale University |
Synthese d'indolocarbazols glycosyles
|
FR2741881B1
(fr)
|
1995-12-01 |
1999-07-30 |
Centre Nat Rech Scient |
Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
|
CA2231105C
(fr)
|
1995-12-08 |
2005-09-13 |
Janssen Pharmaceutica N.V. |
Derives de la (imidazol-5-yl)methyl-2-quinoleinone comme inhibiteur de la proteine farnesyle-transferase
|
KR100447918B1
(ko)
|
1996-07-25 |
2005-09-28 |
동아제약주식회사 |
대장을포함한위장관보호작용을갖는플라본및플라바논화합물
|
ATE309345T1
(de)
|
1996-08-02 |
2005-11-15 |
Genesense Technologies Inc |
Antitumor antisense sequenzen gegen h1 und r2 verbindungen von ribonukleotide reductase
|
CO4950519A1
(es)
|
1997-02-13 |
2000-09-01 |
Novartis Ag |
Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
|
US6126965A
(en)
|
1997-03-21 |
2000-10-03 |
Georgetown University School Of Medicine |
Liposomes containing oligonucleotides
|
EP1017394B1
(fr)
|
1997-07-12 |
2005-12-07 |
Cancer Research Technology Limited |
Derives de purine inhibant la kinase dependant de la cycline
|
US7348025B2
(en)
*
|
1997-09-23 |
2008-03-25 |
Research Development Foundation |
Small particle liposome aerosols for delivery of anticancer drugs
|
GB9800569D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
ES2429573T3
(es)
|
1998-05-29 |
2013-11-15 |
Sugen, Inc. |
Derivado de 2-indolinona sustituido por un pirrol como inhibidor de proteína kinasa
|
US20030083242A1
(en)
|
1998-11-06 |
2003-05-01 |
Alphonse Galdes |
Methods and compositions for treating or preventing peripheral neuropathies
|
CN101121021B
(zh)
|
1999-06-25 |
2011-12-07 |
杰南技术公司 |
人源化抗ErbB2抗体及用抗ErbB2抗体进行的治疗
|
EP1201668A4
(fr)
|
1999-07-13 |
2003-05-21 |
Kyowa Hakko Kogyo Kk |
Derives de staurosporine
|
UA72946C2
(uk)
|
1999-11-05 |
2005-05-16 |
Астразенека Аб |
Похідні хіназоліну як інгібітори васкулярного ендотеліального фактора росту (vegf)
|
NZ520640A
(en)
|
2000-02-15 |
2005-04-29 |
Upjohn Co |
Pyrrole substituted 2-indolinone protein kinase inhibitors
|
CA2406847C
(fr)
|
2000-04-12 |
2009-11-17 |
Genaera Corporation |
Oxydation stereoselective de systemes a cycles fusionnes pour la preparation d'aminosterols
|
TW200914443A
(en)
|
2000-06-30 |
2009-04-01 |
Glaxo Group Ltd |
Process for preparing substituted quinazolinyl furanaldehyde
|
DE60132937T2
(de)
|
2000-09-11 |
2009-02-12 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Verfahren zur Herstellung von Benzimidazol-2-yl -Chinolinonderivaten
|
US6677450B2
(en)
|
2000-10-06 |
2004-01-13 |
Bristol-Myers Squibb Company |
Topoisomerase inhibitors
|
EP1392859B1
(fr)
|
2001-01-16 |
2006-05-10 |
Regeneron Pharmaceuticals, Inc. |
Isolement de cellules exprimant des proteines secretees
|
WO2002062826A1
(fr)
|
2001-02-07 |
2002-08-15 |
Vadim Viktorovich Novikov |
Procede de fabrication des peptides
|
WO2003004505A1
(fr)
|
2001-07-02 |
2003-01-16 |
Debiopharm S.A. |
Substance active a base d'oxaliplatine presentant une faible teneur en acide oxalique
|
KR100484504B1
(ko)
|
2001-09-18 |
2005-04-20 |
학교법인 포항공과대학교 |
쿠커비투릴 유도체를 주인 분자로서 포함하고 있는 내포화합물 및 이를 포함한 약제학적 조성물
|
US20030134846A1
(en)
|
2001-10-09 |
2003-07-17 |
Schering Corporation |
Treatment of trypanosoma brucei with farnesyl protein transferase inhibitors
|
WO2003077902A1
(fr)
|
2002-02-19 |
2003-09-25 |
Xenoport, Inc. |
Procede de synthese de promedicaments a partir de derives de 1-acyl-alkyl et compositions correspondantes
|
DE60329910D1
(de)
|
2002-03-29 |
2009-12-17 |
Novartis Vaccines & Diagnostic |
Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
|
US6900342B2
(en)
|
2002-05-10 |
2005-05-31 |
Dabur India Limited |
Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
|
US6727272B1
(en)
|
2002-07-15 |
2004-04-27 |
Unitech Pharmaceuticals, Inc. |
Leflunomide analogs for treating rheumatoid arthritis
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
WO2004060308A2
(fr)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Thiosemicarbazones antiviraux et immunostimulants
|
ES2391770T3
(es)
|
2003-01-21 |
2012-11-29 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos de triptantrina para la potenciación inmune
|
US7893096B2
(en)
|
2003-03-28 |
2011-02-22 |
Novartis Vaccines And Diagnostics, Inc. |
Use of small molecule compounds for immunopotentiation
|
US20050215795A1
(en)
*
|
2004-02-06 |
2005-09-29 |
Bang-Chi Chen |
Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
|
SI1849470T1
(sl)
|
2005-01-26 |
2017-10-30 |
Taiho Pharmaceutical Co., Ltd. |
Zdravilo proti raku, ki vsebuje alfa,alfa,alfa-trifluorotimidin in zaviralec timidin-fosforilaze
|
JP5709354B2
(ja)
*
|
2005-11-14 |
2015-04-30 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
mTOR阻害剤投与によるがん患者の治療
|
JO2660B1
(en)
*
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
BRPI0709075A2
(pt)
|
2006-03-20 |
2011-10-11 |
Medigene Ag |
tratamento de cáncer de mama triplo receptor negativo
|
BRPI0714908B8
(pt)
|
2006-08-08 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
derivados de pirimidina como inibidor de pi3k, composição farmacêutica e agente preventivo ou agente terapêutico de uma doença proliferativa que os compreende
|
US8222288B2
(en)
*
|
2006-08-30 |
2012-07-17 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of MDM2 and the uses thereof
|
AU2008213808B2
(en)
|
2007-02-06 |
2011-11-10 |
Novartis Ag |
PI 3-kinase inhibitors and methods of their use
|
WO2009066084A1
(fr)
*
|
2007-11-21 |
2009-05-28 |
F. Hoffmann-La Roche Ag |
2-morpholinopyrimidines et leur utilisation en tant qu'inhibiteurs de kinase pi3
|
US20100272717A1
(en)
*
|
2007-12-13 |
2010-10-28 |
Novartis Ag |
Combinations of therapeutic agents for treating cancer
|
WO2009155659A1
(fr)
*
|
2008-06-27 |
2009-12-30 |
The University Of Queensland |
Polythérapie
|
EP2349984A1
(fr)
*
|
2008-10-17 |
2011-08-03 |
Merck & Co. |
Polythérapie
|